05:53 AM EDT, 09/18/2026 (MT Newswires) -- Swiss consumer goods giant Nestlé's (NESN.SW) unit is facing legal action in India over alleged breaches tied to product claims and quality standards for infant nutrition products. The Indian Food Safety and Standards Authority reviewed promotional material available on e-commerce platforms and found that claims made for NAN Excella Pro Stage 1 and Lactogen Pro 1 did not comply with regulations governing foods for infant nutrition, the regulator said in an Instagram post Friday. Meanwhile, laboratory testing found a sample of follow-up formula produced by Nestlé India to be substandard for biotin content, with a referral laboratory later confirming that it failed to meet prescribed requirements. Nestle did not immediately respond to a request for comment from MT Newswires.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.